FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses …
FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism Read More